Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$5.23 - $9.24 $31,411 - $55,495
6,006 Added 301.66%
7,997 $45,000
Q2 2023

Aug 10, 2023

SELL
$4.36 - $6.2 $17,139 - $24,372
-3,931 Reduced 66.38%
1,991 $10,000
Q1 2023

May 11, 2023

SELL
$4.71 - $6.66 $2,062 - $2,917
-438 Reduced 6.89%
5,922 $37,000
Q4 2022

Feb 09, 2023

SELL
$4.06 - $5.71 $101,069 - $142,144
-24,894 Reduced 79.65%
6,360 $29,000
Q3 2022

Nov 10, 2022

SELL
$4.67 - $7.81 $17,937 - $29,998
-3,841 Reduced 10.94%
31,254 $146,000
Q2 2022

Aug 10, 2022

SELL
$5.84 - $20.02 $34,975 - $119,899
-5,989 Reduced 14.58%
35,095 $208,000
Q1 2022

May 12, 2022

BUY
$13.62 - $32.45 $290,078 - $691,120
21,298 Added 107.64%
41,084 $794,000
Q4 2021

Feb 10, 2022

BUY
$32.11 - $47.16 $241,402 - $354,548
7,518 Added 61.28%
19,786 $647,000
Q3 2021

Nov 10, 2021

BUY
$29.63 - $46.98 $363,500 - $576,350
12,268 New
12,268 $502,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $379M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.